A single-center study from the University Hospital of Sassari objectively tested olfactory and gustatory function in 72 COVID-19 patients. The research found that 73.6% of patients reported chemosensitive disorders, with hyposmia in 60 cases and hypogeusia in 33. The dataset was authored by Luigi Angelo Vaira of the University of Sassari.
Use Cases
- Modeling the prevalence of olfactory dysfunction based on patient-reported chemosensitive disorders.
- Analyzing the relationship between age and chemosensitive recovery in COVID-19 patients.
- Investigating the correlation between time from symptom onset and gustatory/olfactory outcomes.
Strengths
- Objective testing of olfactory and gustatory function was performed on 72 patients.
- Study reports specific counts for hyposmia (60 cases) and hypogeusia (33 cases).
- Analysis includes statistically significant differences based on age and time from symptom onset.
Limitations
- Row count and column-level documentation are unknown; field semantics must be inferred after download.
- Data may reflect geographic bias inherent to a single-center study in Sassari.
- Last update date is unknown; freshness unverified.
Provenance
- Source
- University of Sassari
- Collection Method
- Objective clinical testing of olfactory and gustatory function in COVID-19 patients.
- Time Range
- Time range is unknown.
- Freshness
- Last updated date is unknown.
- Geography
- Single-center experience at University Hospital of Sassari.